Skip to content

Useful Information

Letters to Doctors

Subject Date
(D/M/Y)
This link will open in a new windowA probably locally acquired case of dengue fever in 2024 19-6-2024
This link will open in a new windowCAR T-cell medicines: PRAC identifies risk of secondary malignancies of T-cell origin (Letter to Healthcare Professionals) 17-6-2024
This link will open in a new windowVigilance against upsurge of pertussis 24-5-2024
This link will open in a new windowUpdate on increased Seasonal Influenza Activity in Hong Kong 2-5-2024
This link will open in a new windowCHMP recommended new contraindications on the co-administration of Reyataz (Atazanavir) with encorafenib and ivosidenib, and with carbamazepine, phenobarbital, and phenytoin (Letter to Healthcare Professionals) 29-4-2024
This link will open in a new windowThe first local case of dengue fever in 2024 26-4-2024
This link will open in a new windowVigilance against B virus infection and addition of the infection to the list of “Other communicable diseases of topical public health concern” 5-4-2024
This link will open in a new windowEzetrol (ezetimibe) and the risks of drug-induced liver injury and severe cutaneous adverse reactions (Letter to Healthcare Professionals) 28-3-2024
This link will open in a new windowAmiodarone: Assessing the potential risk of primary graft dysfunction following heart transplantation (Letter to Healthcare Professionals) 28-3-2024
This link will open in a new windowIbrance (palbociclib): Assessing the potential risk of venous thromboembolism (Letter to Healthcare Professionals) 28-3-2024
This link will open in a new windowUpdated warnings of faricimab (Vabysmo): retinal vasculitis risk (Letter to Healthcare Professionals) 21-3-2024
This link will open in a new windowColistin (colistimethate sodium): Assessing the potential risk of pseudo-Bartter syndrome (Letter to Healthcare Professionals) 1-3-2024
This link will open in a new windowVigilance against upsurge of measles 29-2-2024
This link will open in a new windowVigilance against ceftriaxone reduced susceptible Neisseria gonorrhoeae infection 30-1-2024
This link will open in a new windowSafety-related information for the product Mifegyne (Letter to Healthcare Professionals) 25-1-2024
This link will open in a new window含mifepristone成分藥品安全資訊 (Letter to Healthcare Professionals) (Chinese only) 24-1-2024
This link will open in a new windowBCMA- and CD19-directed genetically modified autologous chimeric antigen receptor (CAR) T cell immunotherapies: risk of T cell malignancies (Letter to Healthcare Professionals) 24-1-2024
This link will open in a new windowFluoroquinolone antibiotics: must now only be prescribed when other commonly recommended antibiotics are inappropriate in the United Kingdom (Letter to Healthcare Professionals) 23-1-2024
This link will open in a new windowArrival of the 2023/24 Winter Influenza Season in Hong Kong 11-1-2024

Archive
20 Jun 2024